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The metal of choice to treat critical size bone defects are up to today still titanium (Ti) and its 
alloys. These biometals posses advantageous characteristics for bone tissue engineering 
applications including excellent corrosion restistance, superior biocompatibility and 
appropriate mechanical properties. Despite the strong biocompatibility the bone binding 
capacity and the bioactivity of Ti are not sufficient to realise a true bond between the implant 
and the surrounding bone tissue, implying a non-optimal osseointegration. 
In the present work, we studied the immobilisation of the biopolymer gelatin type B onto the 
surface of three dimensional regular Ti scaffolds to improve their surface bio-activity. Gelatin 
is derived from collagen, one of the main constituents of the extracellular matrix, and has 
already been used for numerous industrial, parmaceutical and biomedical applications. The 
successful immobilisation of the gelatin coating was demonstrated by different techniques 
including X-ray photelectron spectroscopy, surface energy determination and fluorescence 
microscopy. Results show a homogeneous coating that is stable for at least 24h in PBS at 
37°C. During subsequent in vitro cell adhesion and culture studies with human periosteal 
derived cells we could observe a homogeneous cell distribution and the onset of a 
mineralisation process. This newly developed coating procedure outperformed the previously 
reported silanisation procedure for immobilising gelatin. 
The bio-activity of these stable gelatin coatings will be further enhanced by applying a 
secondary coating using the cell-attractive protein fibronectin. The reproducible 
immobilisation process developed will allow for a controlled biomolecule presentation to the 
surrounding tissue. 
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